Remote Second Opinion for Glioblastoma: How to Prepare Your Materials and What to Expect From Virtual Consultation

What is a remote second opinion for glioblastoma?

A remote second opinion lets a specialist neuro-oncologist review your diagnosis, pathology results, and MRI scans without you traveling to their hospital. You upload or courier your records. The expert reviews them, and you get findings in writing or on a video call - usually within 5 to 10 business days.

A glioblastoma (GBM) diagnosis is frightening, and the timeline feels brutal. Most patients are told that treatment should begin within four to six weeks of surgery. That window is tight, but it's enough time to get an independent specialist review running alongside your local planning process. Verifying the pathology, the molecular markers, and the proposed treatment approach is standard practice in careful GBM management. Most oncologists expect and support it.

This guide explains exactly what to gather, how to send it, and what to expect once a review is under way.

Why remote reviews work for glioblastoma cases

GBM is rare enough that most regional hospitals see only a handful of new cases each year. Major cancer centers see hundreds. That difference in volume shapes how a specialist reads your imaging and interprets your molecular results.

Telehealth has become standard in neuro-oncology. According to a review published in Neuro-Oncology Practice, virtual consultations allow specialists to review imaging, evaluate treatment response, and advise on clinical trial eligibility without an in-person visit. For patients in the GCC, Sub-Saharan Africa, or South Asia - regions where subspecialty neuro-oncology is limited - that access can shift a treatment plan in important ways.

The NCI notes that people with brain tumors often need specialists at comprehensive cancer centers for diagnosis or a second opinion, and that telehealth removes the geographical barriers that historically made that access impossible for most patients outside major cities.

What a remote neuro-oncology review covers

Not every second-opinion program is the same. A complete GBM remote review should address each of the following areas.

• Pathology confirmation. An independent neuropathologist re-examines the tumor tissue to confirm the diagnosis, the grade, IDH mutation status, and histological subtype.
• Molecular marker review. This includes MGMT promoter methylation - the marker that predicts whether temozolomide chemotherapy will work - plus IDH status, EGFR amplification, TERT promoter mutation, and any markers relevant to clinical trial eligibility.
• MRI interpretation. A specialist reads the pre-operative and post-operative MRI using RANO criteria (Response Assessment in Neuro-Oncology), the standard framework for evaluating GBM imaging changes over time.
• Treatment plan assessment. The reviewer evaluates whether the proposed protocol - typically the Stupp protocol of concurrent chemoradiation followed by adjuvant temozolomide - fits your molecular profile, age, and functional status.
• Clinical trial eligibility check. Major centers cross-reference your molecular results against currently open trials. This step alone can surface options your local team may not be tracking.

For a deeper breakdown of each component and what to look for in the written report, see the Glioblastoma Second Opinion: Components and Checklist on this site.

The eight documents you need to prepare

Pulling records together feels overwhelming when you are already under pressure. Work through this list one item at a time.

1. Pathology report. The written report from the neuropathologist who analyzed the surgical tissue. It should state the tumor grade, histological subtype, and all molecular markers tested. If MGMT methylation or IDH mutation status is missing, flag this specifically - the reviewing team will need those results before completing their assessment.
2. Tumor tissue blocks or unstained slides. Many specialist centers need physical tissue to perform independent re-staining or additional molecular testing. Ask your hospital's pathology department for paraffin-embedded tissue blocks or a set of unstained slides. Most hospitals will prepare these within a few days on a written request. Slides are shipped by tracked international courier with appropriate biohazard packaging.
3. All MRI studies in DICOM format. DICOM is the raw digital format for radiology images - not the compressed screenshots in a patient portal. Request a disc or secure digital link from the radiology department. The reviewing neuroradiologist needs the full DICOM dataset, not just the written radiology report. Include the pre-operative MRI, the post-operative MRI (typically done 24 to 72 hours after surgery), and any subsequent scans.
4. Operative (surgical) report. This document describes what happened during surgery - which brain region was involved, how much tumor was removed, and whether the resection was gross total, near total, or partial. Extent of resection is a key variable in both prognosis and treatment planning.
5. Current medication list. Include the name, dose, and frequency of every drug - corticosteroids such as dexamethasone, anti-epileptic drugs, and any supplements the patient is currently taking.
6. Neurological status summary. A brief clinic letter or functional-status note from the neurologist or neuro-oncologist describing the patient's current cognitive and physical condition, seizure history if applicable, and performance score (ECOG or Karnofsky).
7. Extended molecular testing results. If your hospital ran next-generation sequencing (NGS), FISH for EGFR amplification, or a comprehensive tumor panel, include those reports. If none were done, note this - the reviewing team may recommend additional testing before finalizing their assessment.
8. A brief written history from the caregiver or patient. One to two paragraphs covering when symptoms first appeared, the surgery date, what treatment has happened so far, and any complications. This gives the reviewer context that does not always appear in the formal records.

The complete checklist of reports, scans, and data covers additional detail on obtaining records from hospitals that are slow to release them - a common challenge across several of our primary source markets.

How to send your files securely

Most specialist centers provide a secure patient portal for digital uploads. If that option is not available, encrypted cloud file sharing with a password-protected link and direct encrypted email to the review coordinator work as alternatives. Physical tissue slides require tracked international courier shipping with correct biohazard labeling. Ask the patient coordinator at the receiving center for packaging instructions before you ship anything.

Do not send imaging as compressed JPEGs or PDF screenshots. Both formats lose the resolution the neuroradiologist needs for an accurate read. Your radiology department can provide full DICOM files on a disc or via a secure digital transfer link - this is a standard request they handle regularly.

If you are organizing this from the GCC, West Africa, or South Asia and your hospital is slow to release records, ask the receiving center's coordinator for a formal records-request letter template. Many hospitals respond faster to a written letter from a named institution than to a general patient request. Some reviewing centers will also accept patient-held copies of records when originals cannot be released in time.

What happens on the virtual consultation call

Once all materials arrive and the review is complete - typically 5 to 10 business days after receipt - you receive a written report. Most programs also offer a scheduled video call with the reviewing specialist.

The call usually runs 30 to 60 minutes. The reviewer walks through the findings: what the pathology shows, what the imaging indicates, and what the treatment recommendation is. They state whether they agree with the local plan, note any areas of diagnostic uncertainty, and flag any additional tests they think should happen before treatment begins.

The NCI describes virtual neuro-oncology visits as an opportunity for the reviewing doctor to share their screen and walk through imaging, pathology, and lab findings in real time, while writing out instructions and recommendations the family can refer to later. Come to the call prepared. Useful questions include:

• Does the pathology confirm grade 4 GBM, or is there any diagnostic ambiguity?
• Is the MGMT methylation result reliable given the method used to test it?
• What does the extent of resection mean for the treatment plan?
• Are there open clinical trials this patient's molecular profile would qualify them for?
• Is the proposed protocol consistent with current NCCN or EANO guidelines?
• What should we watch for on the next MRI?

The National Brain Tumor Society states that seeking a specialist review before or shortly after diagnosis is one of the most important steps a newly diagnosed GBM patient can take. The goal is to arrive at your first day of treatment confident that the plan fits the specific biology of this tumor.

What the written report will and will not tell you

A good second-opinion report is direct. It states whether the diagnosis is confirmed, whether the treatment plan aligns with current evidence, and what additional steps the reviewer recommends. It does not guarantee outcomes and does not prescribe specific drug doses or schedules. What it does is give you and your local team a documented, independent assessment from a specialist who reviews a high volume of GBM cases each year.

In some cases, the remote review confirms everything your local team has already concluded. That confirmation still has value - it means you can start treatment without residual doubt. In other cases, the reviewer may identify a molecular marker that was not tested, flag a clinical trial option, or note a discrepancy in the pathology interpretation. The American Brain Tumor Association lists seeking a second opinion as one of the five key steps after a GBM diagnosis, precisely because independent pathology review can - and sometimes does - change the clinical picture.

If you are unsure whether your situation calls for a second opinion at all, the article When to Seek a Glioblastoma Second Opinion outlines the specific scenarios where an independent review is most likely to influence what happens next.

Practical notes for international patients and caregivers

If you are coordinating this from outside the US, UK, or Europe, a few extra steps will help the process run smoothly.

• Confirm the time zone before booking the video call. A 9 AM Eastern US appointment is 5 PM in the UAE and 2 PM in Nigeria. Confirm the exact time zone with the coordinator and build in a few minutes for technology setup on your end.
• Request medical interpretation if needed. Most major centers can arrange interpretation for Arabic, Hindi, Amharic, Swahili, and other languages. Request this at the time of booking, not the day of the call.
• Ask for a plain-language written summary. The full written report may contain dense clinical language. Some centers will produce a summary version on request. Even without one, the written format lets you work through the content at your own pace.
• Clarify what follow-up is included. Some programs offer additional calls during the treatment course. Others provide a one-time report. Know what is included before you submit records and pay any fees.

Dana-Farber Cancer Institute's online second opinion program accepts patients from outside the US and provides clear guidance on how to submit records digitally - a useful reference point for understanding what a well-organized remote review process looks like in practice.

Once you have the report in hand, you can upload your MRI and records through the Glioblastoma Center patient journey form so the team can help you understand what the findings mean for your next steps.

When to talk to your doctor

Tell your oncologist or surgeon early that you plan to seek a remote second opinion. This is standard clinical practice that most oncologists expect and support. Ask for tissue blocks and DICOM files promptly after surgery, since both can take several days to prepare and the post-surgery window is short. If the second-opinion report contradicts your local plan in any significant way, bring the written document to your care team for a direct conversation rather than acting on it independently. The report is input for shared clinical decision-making.

This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.